Insider Transactions in Q3 2025 at Cytek Biosciences, Inc. (CTKB)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 18
2025
|
Philippe Busque SVP, GLOBAL SALES AND SERVICES |
SELL
Payment of exercise price or tax liability
|
Direct |
2,872
-4.17%
|
$11,488
$4.06 P/Share
|
|
Aug 18
2025
|
Philippe Busque SVP, GLOBAL SALES AND SERVICES |
BUY
Exercise of conversion of derivative security
|
Direct |
7,371
+9.61%
|
-
|
|
Aug 18
2025
|
Ming Yan CHIEF TECHNOLOGY OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
5,738
-0.02%
|
$22,952
$4.06 P/Share
|
|
Aug 18
2025
|
Ming Yan CHIEF TECHNOLOGY OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
21,031
+0.09%
|
-
|
|
Aug 18
2025
|
William D. Mc Combe Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,546
-5.48%
|
$30,184
$4.06 P/Share
|
|
Aug 18
2025
|
William D. Mc Combe Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,371
+12.23%
|
-
|
|
Aug 18
2025
|
Wenbin Jiang PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
16,959
-0.08%
|
$67,836
$4.06 P/Share
|
|
Aug 18
2025
|
Wenbin Jiang PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
69,641
+0.33%
|
-
|
|
Aug 18
2025
|
Valerie Barnett CHIEF LEGAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
8,829
-2.3%
|
$35,316
$4.06 P/Share
|
|
Aug 18
2025
|
Valerie Barnett CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
24,307
+5.85%
|
-
|
|
Aug 18
2025
|
Richard Chin |
BUY
Exercise of conversion of derivative security
|
Direct |
4,071
+50.0%
|
-
|
|
Aug 18
2025
|
Michael Holder |
BUY
Exercise of conversion of derivative security
|
Direct |
2,181
+17.65%
|
-
|